Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
As exome and genome sequencing become more commonly used in medical care, doctors will increasingly be able to learn about genetic changes that increase an individual's risk for developing an unrelated disease. In the past, these incidental genetic findings (unrelated to the condition for which the patient was tested) were seldom provided to the patient.

A report summarising the current treatment options and directions for future research in the management of epilepsy associated with Tuberous sclerosis complex (TSC) has been published in the European Journal of Paediatric Neurology 2012. The recommendations follow the TSC consensus meeting of European experts for SEGA and Epilepsy management in March 2012, Rome, Italy.